Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Single-Blind, Randomized, Dose-Escalation, Placebo-Controlled, Multiple Dose, Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of INT101 Intramuscular Injection in Healthy Adults

NCT07818629 is registered in ClinicalTrials.gov with InThera Inc. Korea as lead sponsor.

NCT NCT07818629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07818629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Single-Blind, Randomized, Dose-Escalation, Placebo-Controlled, Multiple Dose, Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of INT101 Intramuscular Injection in Healthy Adults
Lead sponsor
InThera Inc. Korea
Phase
Phase 1
Overall status
Recruiting
Start date
August 10, 2026
Completion date
January 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

norovirus gastroenteritis, norovirus infections